237 related articles for article (PubMed ID: 20179157)
41. Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine kinase-2.
Fitzpatrick LR; Green C; Maines LW; Smith CD
Pharmacology; 2011; 87(3-4):135-43. PubMed ID: 21346391
[TBL] [Abstract][Full Text] [Related]
42. TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition.
Lima S; Takabe K; Newton J; Saurabh K; Young MM; Leopoldino AM; Hait NC; Roberts JL; Wang HG; Dent P; Milstien S; Booth L; Spiegel S
Autophagy; 2018; 14(6):942-957. PubMed ID: 29368980
[TBL] [Abstract][Full Text] [Related]
43. Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis.
Kotelevets N; Fabbro D; Huwiler A; Zangemeister-Wittke U
PLoS One; 2012; 7(6):e39209. PubMed ID: 22761740
[TBL] [Abstract][Full Text] [Related]
44. The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells.
Watson DG; Tonelli F; Alossaimi M; Williamson L; Chan E; Gorshkova I; Berdyshev E; Bittman R; Pyne NJ; Pyne S
Cell Signal; 2013 Apr; 25(4):1011-7. PubMed ID: 23314175
[TBL] [Abstract][Full Text] [Related]
45. Ablation of sphingosine kinase-2 inhibits tumor cell proliferation and migration.
Gao P; Smith CD
Mol Cancer Res; 2011 Nov; 9(11):1509-19. PubMed ID: 21896638
[TBL] [Abstract][Full Text] [Related]
46. Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase.
Fitzpatrick LR; Green C; Frauenhoffer EE; French KJ; Zhuang Y; Maines LW; Upson JJ; Paul E; Donahue H; Mosher TJ; Smith CD
Inflammopharmacology; 2011 Apr; 19(2):75-87. PubMed ID: 20936538
[TBL] [Abstract][Full Text] [Related]
47. Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.
Bandara G; Muñoz-Cano R; Tobío A; Yin Y; Komarow HD; Desai A; Metcalfe DD; Olivera A
Front Immunol; 2018; 9():631. PubMed ID: 29643855
[TBL] [Abstract][Full Text] [Related]
48. Autophagy induced by deficiency of sphingosine-1-phosphate phosphohydrolase 1 is switched to apoptosis by calpain-mediated autophagy-related gene 5 (Atg5) cleavage.
Lépine S; Allegood JC; Edmonds Y; Milstien S; Spiegel S
J Biol Chem; 2011 Dec; 286(52):44380-90. PubMed ID: 22052905
[TBL] [Abstract][Full Text] [Related]
49. Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma.
Hui B; Shi YH; Ding ZB; Zhou J; Gu CY; Peng YF; Yang H; Liu WR; Shi GM; Fan J
Cancer; 2012 Nov; 118(22):5560-71. PubMed ID: 22517429
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.
Maines LW; Fitzpatrick LR; Green CL; Zhuang Y; Smith CD
Inflammopharmacology; 2010 Apr; 18(2):73-85. PubMed ID: 20151210
[TBL] [Abstract][Full Text] [Related]
51. Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells.
Hu H; Chai Y; Wang L; Zhang J; Lee HJ; Kim SH; Lü J
Mol Cancer Ther; 2009 Oct; 8(10):2833-43. PubMed ID: 19825802
[TBL] [Abstract][Full Text] [Related]
52. Justicidin A-induced autophagy flux enhances apoptosis of human colorectal cancer cells via class III PI3K and Atg5 pathway.
Won SJ; Yen CH; Liu HS; Wu SY; Lan SH; Jiang-Shieh YF; Lin CN; Su CL
J Cell Physiol; 2015 Apr; 230(4):930-46. PubMed ID: 25216025
[TBL] [Abstract][Full Text] [Related]
53. Examining the Role of Sphingosine Kinase-2 in the Regulation of Endothelial Cell Barrier Integrity.
Dimasi DP; Pitson SM; Bonder CS
Microcirculation; 2016 Apr; 23(3):248-65. PubMed ID: 26822263
[TBL] [Abstract][Full Text] [Related]
54. A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties.
Pitman MR; Powell JA; Coolen C; Moretti PA; Zebol JR; Pham DH; Finnie JW; Don AS; Ebert LM; Bonder CS; Gliddon BL; Pitson SM
Oncotarget; 2015 Mar; 6(9):7065-83. PubMed ID: 25788259
[TBL] [Abstract][Full Text] [Related]
55. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.
Paugh SW; Paugh BS; Rahmani M; Kapitonov D; Almenara JA; Kordula T; Milstien S; Adams JK; Zipkin RE; Grant S; Spiegel S
Blood; 2008 Aug; 112(4):1382-91. PubMed ID: 18511810
[TBL] [Abstract][Full Text] [Related]
56. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
Pchejetski D; Bohler T; Brizuela L; Sauer L; Doumerc N; Golzio M; Salunkhe V; Teissié J; Malavaud B; Waxman J; Cuvillier O
Cancer Res; 2010 Nov; 70(21):8651-61. PubMed ID: 20959468
[TBL] [Abstract][Full Text] [Related]
57. The role of autophagy in human endometrium.
Choi J; Jo M; Lee E; Oh YK; Choi D
Biol Reprod; 2012 Mar; 86(3):70. PubMed ID: 22088918
[TBL] [Abstract][Full Text] [Related]
58. SK1 Inhibitor RB005 Induces Apoptosis in Colorectal Cancer Cells through SK1 Inhibition Dependent and Independent Pathway.
Shrestha J; Shamshiddinova M; Lee YM; Oh YS; Baek DJ; Park EY
Curr Mol Pharmacol; 2022; 15(3):570-581. PubMed ID: 34382511
[TBL] [Abstract][Full Text] [Related]
59. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
60. OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma.
Gao M; Yeh PY; Lu YS; Hsu CH; Chen KF; Lee WC; Feng WC; Chen CS; Kuo ML; Cheng AL
Cancer Res; 2008 Nov; 68(22):9348-57. PubMed ID: 19010909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]